Skip to main content

Table 1 Demographic and baseline characteristics

From: Low free triiodothyronineis predicts worsen neurological outcome of patients with acute ischemic stroke: a retrospective study with bioinformatics analysis

Variables

Total

AIS

Non-AIS

p value

Sex(n)

403

221

182

NS

Male

233

129

104

 

Female

170

92

78

 

Age (years)

64.65 ± 10.85

66.80 ± 7.78

63.13 ± 12.51

NS

Hypertension (n)

   

0.003

 Yes

165

105

60

 

 No

238

116

122

 

Diabetes (n)

   

0.001

 Yes

116

79

37

 

 No

287

142

145

 

Hyperlipidemia (n)

   

0.011

 Yes

161

101

60

 

 No

242

120

122

 

Hyperhomocysteinemia (n)

   

< 0.0001

 Yes (> 15 μmol/L)

111

85

26

 

 No (≦ 15 μmol/L)

292

136

156

 

Smoking (n)

   

< 0.0001

 Yes

128

88

40

 

 No

275

133

142

 

Drinking (n)

   

< 0.0001

 Yes

94

70

24

 

 No

309

151

158

 

Atrial fibrillation (n)

   

0.022

 Yes

43

31

12

 

 No

360

190

170

 

Stroke history (n)

   

< 0.0001

 Yes

109

89

20

 

 No

281

132

149

 

with Periventricular WMH

   

0.006

 Grade 1

81

46

35

 

 Grade 2

44

32

11

 

 Grade 3

26

23

3

 

with subcortical WMH

   

0.012

 Grade 1

74

42

32

 

 Grade 2

43

31

12

 

 Grade 3

29

25

4

 

with lacunas (n)

   

< 0.0001

 Yes

163

113

50

 

 No

240

108

132

 

FT3, pmol/L

4.5870 ± 0.7737

4.26 ± 0.49

4.65 ± 0.24

0.002

FT4, pmol/L

16.59 ± 2.42

16.77 ± 2.52

16.35 ± 2.57

NS

TSH, uIU/ml

2.33 ± 0.74

1.95 ± 0.54

2.49 ± 0.65

NS

FT3/FT4

0.27 ± 0.05

0.25 ± 0.04

0.29 ± 0.05

0.004

  1. AIS acute ischemic stroke; WMH white matter hyperintensity; FT3 free triiodothyronine; FT4 free thyroxine; TSH thyroid stimulating hormone